Invention Grant
- Patent Title: Fibronectin type III domain based scaffold compositions, methods and uses
-
Application No.: US14921589Application Date: 2015-10-23
-
Publication No.: US10040842B2Publication Date: 2018-08-07
- Inventor: Steven Jacobs , Karyn O'Neil
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Main IPC: C40B40/08
- IPC: C40B40/08 ; C07K14/78 ; C40B50/06

Abstract:
A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG have been identified as useful for diagnostic and/or therapeutic applications.
Public/Granted literature
- US20160039909A1 Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses Public/Granted day:2016-02-11
Information query